Delayed referrals, diagnoses undermine cancer patients' faith in health care system
the ONA take:
Analysis of data from a survey conducted by Cancer Research UK scientists revealed that timeliness of referral for cancer tests can have a significant impact on patients’ overall satisfaction with their care and their health care team.
Of the nearly 60,000 survey respondents whose diagnoses were made through their GPs, 23% had been seen three or more times before a referral for cancer tests was given.
Furthermore, these patients were more likely to report negative experiences across 10 of 12 different aspects of their care compared with those patients who were referred after one or two visits with their GPs.
Aspects of care in which patients were dissatisfied included the way they were informed of their diagnosis, how well hospital and GPs worked together to provide care, and confidence and trust in ward nurses.
Although diagnostic delays can be caused by the difficulty in distinguishing cancer symptoms from other diseases and a lack of accurate and easy-to-use tests, the survey results demonstrate the significance of early diagnosis on patients’ overall experience with cancer care.
The researchers report that timeliness of diagnosis is an important factor in patients’ overall experience in their cancer journey.
Timeliness of referral for cancer tests can have a significant impact on patients’ overall satisfaction.
- Ixazomib, a New PI, Offers Improved Efficacy With Acceptable Toxicity Profile for Relapsed/Refractory Multiple Myeloma
- Acupuncture May Improve Fatigue in Patients with Lung Cancer
- "Light" Cigarettes and Cancer Risk (Fact Sheet)
- A Review of CDK4/6 Toxicities and Interactions Management in Breast Cancer
- Vitamin D3 Supplementation Has No Impact on Breast Density Percentage, Breast Cancer Risk
- Dexamethasone-Induced Hiccups in Chemotherapy May be Prevented by Rotating to Methylprednisolone
- New Evidence Shows Metastases May Spread Independently of Lymph Nodes
- Long Term Survivors of Prostate Cancer Express Treatment Decision Regret for Up to 15 Years
- FDA Expands Clearance for Cooling Cap Use With Chemotherapy for Solid Tumors
- Recommendations for Vaccine Administration During Chemotherapy
- Risk for Prostate Cancer Not Associated With Vasectomy, Meta-analysis Affirms
- Disease-Free Survival After Breast Cancer Comparable With Exemestane, Sequential Tamoxifen/Exemestane
- Treating the Other "Patient": Depressive Symptoms Are Predictive of Declining Physical Health in Caregivers
- Oropharyngeal Mucositis Pain Effectively Relieved With Indomethacin Oral Spray
- Opioids Overprescribed in Patients Undergoing Surgery
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|